Changes in Renal Function Following Nephroureterectomy May Affect the Use of Perioperative Chemotherapy

References

Page 1

	Year	Citations
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation Andrew S. Levey, Juan Bosch, Julia B. Lewis, Annals of Internal Medicine	1999	15K
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization Alan S. Go, Glenn M. Chertow, Dongjie Fan, New England Journal of Medicine	2004	11.2K
Cancer Statistics, 2009 Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward, CA A Cancer Journal for Clinicians Epidemiology Of CancerPathologyCancer RegistrationMortality RatesUnited States	2009	9.7K
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer H. Barton Grossman, Ronald B. Natale, Catherine M. Tangen, New England Journal of Medicine	2003	2.6K
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction Nagesh S. Anavekar, John J.V. McMurray, Eric J. Velazquez, New England Journal of Medicine	2004	1.9K
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study William C. Huang, Andrew S. Levey, Angel M. Serio, The Lancet Oncology Retrospective Cohort StudyUrologyRenal DiseaseSurgical OncologyRenal Function	2006	1.6K
Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration Vitaly Margulis, Shahrokh F. Shariat, Surena F. Matin, Cancer	2009	1.1K
Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients M. Craig Hall, Sean Womack, Arthur I. Sagalowsky, Urology Prognostic FactorsUrological ResearchUrologySurgical OncologyTransitional Cell Carcinoma	1998	669
UPPER TRACT UROTHELIAL NEOPLASMS: INCIDENCE AND SURVIVAL DURING THE LAST 2 DECADES J J Munoz, Lars M. Ellison The Journal of Urology	2000	574
Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial Luigi Dogliotti, Giacomo Cartenì, Salvatore Siena, European Urology UrologyGenitourinary CancerMedicineCisplatin Versus GemcitabineCancer Treatment	2007	326

Page 1